Comments
Sanofi strong in emerging markets as rivals flag
28.04.2012. | PARIS (Reuters) - French drugmaker Sanofi posted better-than-expected quarterly results, bolstered by strong emerging markets, breaking with a trend of earnings misses by European rivals AstraZeneca and GlaxoSmithkline....
